InsidersTradesSigma
Ascelia Pharma AB: management transactions · Finland · FIN-FSA
FI:ascelia-pharma-ab-a7bff6SE0010573113FI·FIN-FSAMcap 393M€Healthcare
Browse the full directors' dealings record of Ascelia Pharma AB, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Ascelia Pharma AB has logged 6 public disclosures. Market capitalisation: €393.3m. The latest transaction was reported on 26 November 2025 — Purchase. Among the most active insiders: Magnus Olafsson Corfitzen. Every trade is openly available.
6
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2.94 €
Analyst consensus
4 analystsStrong buy
3.70 €Target 5.60 €(+90%)8.50 €
Income statement
Net income−76.3 M€0.0% margin
Valuation
PER (forward)29.4x
P/Book3.8x
Beta0.89
Balance sheet & cash
Market cap393.3 M€
Total debt970 k€
Free Cash Flow−72.3 M€
Debt / Equity1%
Profitability & ownership
ROE-100.8%
ROA-40.4%
% insiders16.7%
% institutions21.8%
Last declaration on 26 November 2025
Declarations6 total
Executives●Purchase28FIN-FSA
024,975 shares0
Aktie
FI:A003U165-1·
Ideal exit: 22 Aug 2026 (T+270)
Executives●Purchase13FIN-FSA
01,754 shares0
Aktie
FI:A003U157-1·
Ideal exit: 22 Aug 2026 (T+270)
Executives●Other15FIN-FSA
€1,1856,152 shares@ €0.19270.0003% mcap22.1% of flow
Aktie
FI:A003N440-1·
Executives●Other21FIN-FSA
€4,17921,688 shares@ €0.19270.0011% mcap77.9% of flow
Warrant
FI:A003N439-1·
Executives●Other21FIN-FSA
€1,92710,000 shares@ €0.19270.0005% mcap100.0% of flow
Aktie
FI:A003N414-1·
Executives●Other36FIN-FSA
€19,268100,000 shares@ €0.19270.0049% mcap100.0% of flow
Aktie
FI:A003N410-1·
6 of 6 declarations